STOCK IN NEWS

• JSW Energy: The company has signed definitive agreements to acquire an additional stake in Toshiba JSW Power Systems from Toshiba Corporation for ₹150 crore. Post-acquisition, JSW Energy’s stake in the joint venture will increase to 20.7 percent on a non-diluted basis and 10.7 percent on a fully diluted basis, strengthening its thermal power equipment supply chain.
• Maruti Suzuki India: The automaker has commenced commercial production at the second unit of its Kharkhoda manufacturing facility in Haryana, effective May 18.
• Sun Pharma Advanced Research Company: The company’s licensing partner, Ocuvex Therapeutics, has received a Complete Response Letter (CRL) from the USFDA for the PDP-716 New Drug Application (NDA).
• Aditya Birla Capital: The company has received a Certificate of Registration from the Reserve Bank of India to commence factoring business operations.
• Mankind Pharma: The pharma major reported a 31.7 percent YoY rise in Q4FY26 net profit to ₹554 crore, while revenue increased 11.8 percent to ₹3,443 crore.
• Godawari Power and Ispat: The company posted a 26.6 percent YoY increase in consolidated Q4FY26 net profit to ₹280.1 crore. Revenue from operations grew 9.7 percent to ₹1,610.3 crore.
• Orkla India: The FMCG company reported a 107 percent YoY jump in Q4FY26 net profit to ₹73 crore, while revenue from operations rose 5 percent to ₹626 crore.
• PTC India: The company’s Q4FY26 net profit declined 69.3 percent YoY to ₹105 crore, despite a 33.3 percent rise in revenue to ₹3,897.5 crore.
• Bharat Petroleum Corporation Limited: BPCL reported a 57.7 percent quarter-on-quarter decline in Q4 net profit to ₹3,192 crore, impacted by exceptional items worth ₹4,349 crore.

BULK DEALS

• Jaro Institute of Technology Management and Research: Singularity Growth Opportunities Fund II exited Jaro Education by selling 2.8 lakh shares (1.27 percent stake) worth ₹14.08 crore at ₹501.33 per share.
• Indian Emulsifiers: Prudent Equity, founded by Siddharth Oberoi, sold 1 lakh shares (0.54 percent stake) in the company for ₹51.89 lakh at ₹51.89 per share.
• Choksi Laboratories: Nexus Global Opportunities Fund acquired an additional 68,727 shares (0.98 percent stake) worth ₹70.82 lakh at ₹103.05 per share.